Roche

Edwards Lifesciences

Follow

Edwards Lifesciences (NYSE: EW) is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. For our legal terms and trademarks, please visit: http://bit.ly/2fv28iO

Ritedose

Follow

Founded in 1995 in Columbia, S.C., The Ritedose Corporation is an industry leader in pharmaceutical development, aseptic cGMP manufacturing and 503B outsourcing solutions, and has mastered blow-fill-seal (BFS) technology to ensure sterile, efficient, consistent and safe unit dose delivery. Our customers range from small startups and large pharmaceutical companies to wholesalers, retail pharmacies and hospital systems; 99% are U.S. companies. Our highly touted, 27-year track record includes delivery of more than 10 billion doses since 2012 without a single interruption and an exceptional inspection history and compliance record as noted by regulators, including the U.S. Food & Drug Administration, multiple state Boards of Pharmacy, U.S. Pharmacopeia and the National Association of Boards of Pharmacy. TRC has grown from 11 people occupying a 52,000 sq ft facility with an annual capacity of 42 million units, into a BFS manufacturing leader with more than 500 employees occupying 273,000 sq ft manufacturing and packaging facility with an annual capacity of 2+ billion units. We are extremely proud of our culture, which is governed by our Quality System and the belief that every associate provides value during each step of the process from development through commercialization and ultimately distribution to patients all over the United States.

Beckman Coulter Diagnostics

Follow

A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services.

Stanford University

Follow

Stanford is one of the world's leading research universities, boasting respected and entrepreneurial programs in business, earth, engineering, law, medicine, education and humanities and sciences. Stanford serves approximately 7,000 undergraduate students and 9,000 graduate students with a student-teacher ratio of about 4:1. In 2015, Stanford has over 5,000 research projects with a $1.33 billion budget. There are 2,200 faculty members and 13,000 staff members, including employees in the SLAC National Accelerator Laboratory, which is a partnership with the Department of Energy. Stanford’s campus, consisting of over 8,000 acres, continues to expand beyond The Farm. As the campus grows, with locations throughout Santa Clara and San Mateo counties, so does our pioneering spirit and ability to innovate, discover and explore new fields. A private institution, Stanford is supported through an endowment of more than $21 billion, one of the largest in the US.

GRAIL

Follow

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL has locations in Menlo Park, California Raleigh / Durham NC, Washington DC and the UK. For more information, please visit www.grail.com

Galderma

Follow

Since Galderma’s foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ: the skin. We are recognized for our innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market. Galderma is strategically positioned in this market across three resilient, highly attractive sub-segments: Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Our unique Integrated Dermatology Strategy is our differentiating factor and the driving force behind our growth. We remain at the forefront of dermatological innovation thanks to our integrated, in-house research and development (R&D) platform. This is driven by deep scientific expertise and synergies across all product categories. Our expertise extends beyond Galderma itself and into our network. We work in close partnership with healthcare professionals to earn their trust and to meet individual consumer and patient needs, with superior outcomes. We have revolutionized how we engage with our key audiences. We place them at the center of everything we do: we listen to their needs and adapt accordingly, which builds trust in our brands. With over 20 brands in three sub-segments, we are one global team working together toward a shared purpose: advancing dermatology for every skin story. We have a high-performance culture of setting ourselves ambitious goals and following up with excellent execution. Together, we are pursuing our ambition of becoming the world's undisputed dermatology powerhouse.